Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch Study: Finasteride to Dutasteride
NCT00690950Phase 4Unknown
- Sponsor
- Urologic Consultants of Southeastern Pennsylvania
- Start
- May 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dutasteride in benign prostatic hyperplasia (BPH), sponsored by Urologic Consultants of Southeastern Pennsylvania. Primary endpoints: Serum Testosterone Level at 12 months, Serum Dihydrotestosterone Level at 12 months and 1 more. Status: unknown.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00690950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690950.